Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Capital Reinvestment Ratio
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd capital reinvestment ratio. Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has a Capital Reinvestment Ratio of 0.20x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥36.25 Million) in capital expenditures (CN¥7.27 Million). See 000766 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (2000–2025)
Capital reinvestment ratio of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd from 2000 to 2025. This chart tracks Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's Capital Reinvestment Ratio across 21 annual periods. See 000766 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Capital Reinvestment Ratio by Year (2000–2025)
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd capital reinvestment ratio by year from 2000 to 2025. For the full cash flow conversion analysis, see 000766 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.61x | CN¥105.05 Million | CN¥64.07 Million | ▲ +101.8% |
| 2024 | 0.30x | CN¥162.75 Million | CN¥49.17 Million | ▲ +27.8% |
| 2023 | 0.24x | CN¥112.78 Million | CN¥26.67 Million | ▲ +97.4% |
| 2022 | 0.12x | CN¥198.16 Million | CN¥23.74 Million | ▼ -34.9% |
| 2021 | 0.18x | CN¥138.33 Million | CN¥25.48 Million | ▼ -22.4% |
| 2020 | 0.24x | CN¥80.71 Million | CN¥19.16 Million | ▼ -70.9% |
| 2019 | 0.81x | CN¥74.86 Million | CN¥60.98 Million | ▲ +86.9% |
| 2018 | 0.44x | CN¥170.72 Million | CN¥74.40 Million | ▼ -90.2% |
| 2017 | 4.47x | CN¥26.43 Million | CN¥118.10 Million | ▲ +139.0% |
| 2016 | 1.87x | CN¥90.63 Million | CN¥169.40 Million | ▼ -65.0% |
| 2014 | 5.34x | CN¥34.32 Million | CN¥183.39 Million | ▲ +249.0% |
| 2013 | 1.53x | CN¥102.96 Million | CN¥157.66 Million | ▲ +336.0% |
| 2010 | 0.35x | CN¥29.05 Million | CN¥10.20 Million | ▲ +113.7% |
| 2009 | 0.16x | CN¥79.94 Million | CN¥13.14 Million | ▼ -77.5% |
| 2008 | 0.73x | CN¥10.26 Million | CN¥7.48 Million | ▲ +41.6% |
| 2007 | 0.51x | CN¥9.95 Million | CN¥5.12 Million | ▲ +4.8% |
| 2005 | 0.49x | CN¥35.74 Million | CN¥17.55 Million | ▲ +115.1% |
| 2004 | 0.23x | CN¥19.12 Million | CN¥4.37 Million | ▼ -74.6% |
| 2003 | 0.90x | CN¥91.99 Million | CN¥82.57 Million | ▲ +277.1% |
| 2002 | 0.24x | CN¥72.70 Million | CN¥17.31 Million | ▼ -87.0% |
| 2000 | 1.84x | CN¥196.15 Million | CN¥360.49 Million | — |